Objective
The purpose of the present study was to investigate cardiovascular autonomic dysfunction in patients with Parkinson’s disease (PD) with mild to severe stages of motor symptoms and to compare cardiovascular autonomic dysfunction between drug-naïve and dopaminergic drug-treated groups.
Methods
This study included 188 PD patients and 25 age-matched healthy controls who underwent head-up tilt-testing, 24-h ambulatory blood pressure (BP) monitoring and 24-h Holter monitoring. Autonomic function test results were evaluated among groups categorized by motor symptom severities (mild vs. moderate vs. severe) and treatment (drug-naïve or dopaminergic drug treatment).
Results
Orthostatic hypotension and supine hypertension were more frequent in patients with PD than in healthy controls. The frequencies of orthostatic hypotension, supine hypertension, nocturnal hypertension and non-dipping were not different among groups. Additionally, no significant differences were detected in supine BP, orthostatic BP change, nighttime BP, nocturnal BP dipping, or heart rate variabilities among groups.
Conclusions
Cardiovascular autonomic dysfunction is not confined to moderate to severe PD patients, and starts early in the course of the disease in a high proportion of PD patients. In addition, dopaminergic drug treatments do not affect cardiovascular autonomic function.
Citations
Citations to this article as recorded by
Parkinson's disease patients with absence of normal dipping status were more vulnerable to cognitive impairment from the early stages Lanlan Chen, Li Jiang, Chenxin Wang, Tingting Qiao, Cancan Ma, Yingzhu Chen, Chunfeng Liu, Xin Wang, Yao Xu Parkinsonism & Related Disorders.2024; 121: 106013. CrossRef
Associations of sleep-related variables with reverse dipping patterns of blood pressure in α-synucleinopathies Yunchuang Sun, Luhua Wei, Fan Li, Chen Ling, Fei Zhai, Yunfeng Lv, Hong Zhou, Cheng Zhang, Jing Ma, Jing Chen, Wei Sun, Zhaoxia Wang Parkinsonism & Related Disorders.2024; 121: 106046. CrossRef
Electrocardiographic approach strategies in patients with Parkinson disease treated with deep brain stimulation Carlos Rafael Sierra-Fernández, Luis Rodrigo Garnica-Geronimo, Alejandra Huipe-Dimas, Jorge A. Ortega-Hernandez, María Alejandra Ruiz-Mafud, Amin Cervantes-Arriaga, Ana Jimena Hernández-Medrano, Mayela Rodríguez-Violante Frontiers in Cardiovascular Medicine.2024;[Epub] CrossRef
Autonomic control of heart and vessels in patients with very early stage of Parkinson disease J Oleksakova, M Javorka, B Czippelova, N Mazgutova, M Grofik, L Babalova, P Skacik, E Kurca Physiological Measurement.2023; 44(5): 054002. CrossRef
Multi-session transcutaneous auricular vagus nerve stimulation for Parkinson's disease: evaluating feasibility, safety, and preliminary efficacy Daniel H. Lench, Travis H. Turner, Colin McLeod, Heather A. Boger, Lilia Lovera, Lisa Heidelberg, Jordan Elm, Anh Phan, Bashar W. Badran, Vanessa K. Hinson Frontiers in Neurology.2023;[Epub] CrossRef
Central Aortic Pressure and Arterial Stiffness in Parkinson’s Disease: A Comparative Study Mehmet Balal, Meltem Demirkiran, Saime Paydas, Seyed-Mohammad Fereshtehnejad Parkinson's Disease.2022; 2022: 1. CrossRef
Blood Pressure Patterns in Patients with Parkinson’s Disease: A Systematic Review Delia Tulbă, Liviu Cozma, Paul Bălănescu, Adrian Buzea, Cristian Băicuș, Bogdan Ovidiu Popescu Journal of Personalized Medicine.2021; 11(2): 129. CrossRef
Inverted circadian variation of arterial pressure in a geriatric patient: an indicator of autonomic dysfunction Siddhartha Lieten, Aziz Debain, Bert Bravenboer, Tony Mets BMC Geriatrics.2021;[Epub] CrossRef
Autonomic dysfunction and heart rate variability with Holter monitoring: a diagnostic look at autonomic regulation Beatrice De Maria, Laura Adelaide Dalla Vecchia, Alberto Porta, Maria Teresa La Rovere Herzschrittmachertherapie + Elektrophysiologie.2021; 32(3): 315. CrossRef
Heart Rate Variability Analyses in Parkinson’s Disease: A Systematic Review and Meta-Analysis Konstantin G. Heimrich, Thomas Lehmann, Peter Schlattmann, Tino Prell Brain Sciences.2021; 11(8): 959. CrossRef
Association of orthostatic hypotension with Parkinson’s disease: a meta-analysis Feifei Mu, Qian Jiao, Xixun Du, Hong Jiang Neurological Sciences.2020; 41(6): 1419. CrossRef
Dizziness in patients with early stages of Parkinson's disease: Prevalence, clinical characteristics and implications Kyum‐Yil Kwon, Suyeon Park, Mina Lee, Hyunjin Ju, Kayeong Im, Byung‐Euk Joo, Kyung Bok Lee, Hakjae Roh, Moo‐Young Ahn Geriatrics & Gerontology International.2020; 20(5): 443. CrossRef
The Dysfunctional Autonomic Function and “Dysfunctional” Fatigue in Drug Naïve Parkinson’s Disease Jong Hyeon Ahn, Minkyeong Kim, Jun Kyu Mun, Yoonsu Cho, Ji Sun Kim, Jinyoung Youn, Joong-Seok Kim, Jin Whan Cho Journal of Parkinson's Disease.2020; 10(2): 605. CrossRef
Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists Ji-Hyun Choi, Jong-Min Kim, Hee Kyung Yang, Hyo-Jung Lee, Cheol Min Shin, Seong Jin Jeong, Won-Seok Kim, Ji Won Han, In-Young Yoon, Yoo Sung Song, Yun Jung Bae Journal of Korean Medical Science.2020;[Epub] CrossRef
Autonomic Dysfunction in Parkinson's Disease Ronald F. Pfeiffer Neurotherapeutics.2020; 17(4): 1464. CrossRef
Dysautonomia Is Linked to Striatal Dopamine Deficits and Regional Cerebral Perfusion in Early Parkinson Disease Hae-Won Shin, Seok Jong Chung, Sangwon Lee, Jungho Cha, Young H. Sohn, Mijin Yun, Phil Hyu Lee Clinical Nuclear Medicine.2020; 45(8): e342. CrossRef
Characteristics of the 24-h ambulatory blood pressure monitoring in patients with Parkinson's disease – the SFC BP multicentre study in China Shi-Wu Chen, Yu-Kai Wang, Rong-Hua Dou, Xin-Yi Xie, Yong-Bo Hu, Nan Ding, Guo-Hua Zhang, Hai-Fang Jing, Wei-Dong Zhao, Yan Xue, Yan Li, Gang Wang Journal of Hypertension.2020; 38(11): 2270. CrossRef
Parkinson’s disease with orthostatic hypotension: analyses of clinical characteristics and influencing factors Lixia Li, Peng Guo, Duyu Ding, Tenghong Lian, Lijun Zuo, Fenghe Du, Wei Zhang Neurological Research.2019; 41(8): 734. CrossRef
Neurogenic Orthostatic Hypotension in
Parkinson Disease: A Primer Jeremy K. Cutsforth-Gregory, Phillip A. Low Neurology and Therapy.2019; 8(2): 307. CrossRef
Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson’s disease Claudia Carricarte Naranjo, Connie Marras, Naomi P. Visanji, David J. Cornforth, Lazaro Sanchez-Rodriguez, Birgitt Schüle, Samuel M. Goldman, Mario Estévez, Phyllis K. Stein, Anthony E. Lang, Herbert F. Jelinek, Andrés Machado Clinical Autonomic Research.2019; 29(6): 603. CrossRef
Considerations before initiating therapy in Parkinsonism: basing on the quality of life Shu-Jin He, Zhen-Yang Liu, Yu-Jie Yang, Cong Shen, Yu-Jie Du, Xin-Yue Zhou, Jue Zhao, Yi-Min Sun, Ke Yang, Jian-Jun Wu, Feng-Tao Liu, Jian Wang Journal of Neurology.2019; 266(12): 3119. CrossRef
Increased risk of all‐cause mortality associated with domperidone use in Parkinson's patients: a population‐based cohort study in the UK Marina Simeonova, Frank de Vries, Sander Pouwels, Johanna H. M. Driessen, Hubert G.M. Leufkens, Suzanne M. Cadarette, Andrea M. Burden British Journal of Clinical Pharmacology.2018; 84(11): 2551. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Cardiovascular Autonomic Dysfunction in Patients with Drug-Induced Parkinsonism Joong-Seok Kim, Dong-Woo Ryu, Ju-Hee Oh, Yang-Hyun Lee, Sung-Jin Park, Kipyung Jeon, Jong-Yun Lee, Seong Hee Ho, Jungmin So, Jin Hee Im, Kwang-Soo Lee Journal of Clinical Neurology.2017; 13(1): 15. CrossRef
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype? J.‐S. Kim, H.‐E. Park, I.‐S. Park, Y.‐S. Oh, D.‐W. Ryu, I.‐U. Song, Y.‐A. Jung, I. R. Yoo, H.‐S. Choi, P. H. Lee, K.‐S. Lee European Journal of Neurology.2017; 24(2): 349. CrossRef
The composite autonomic symptom scale 31 is a useful screening tool for patients with Parkinsonism Younsoo Kim, Jin Myoung Seok, Jongkyu Park, Kun-Hyun Kim, Ju-Hong Min, Jin Whan Cho, Suyeon Park, Hyun-jin Kim, Byoung Joon Kim, Jinyoung Youn, Pedro Gonzalez-Alegre PLOS ONE.2017; 12(7): e0180744. CrossRef
Cardiac sympathetic denervation predicts PD in at-risk individuals David S. Goldstein, Courtney Holmes, Grisel J. Lopez, Tianxia Wu, Yehonatan Sharabi Parkinsonism & Related Disorders.2017;[Epub] CrossRef
Loss of cutaneous large and small fibers in naive and
l
-dopa–treated PD patients
Maria Nolano, Vincenzo Provitera, Fiore Manganelli, Rosa Iodice, Annamaria Stancanelli, Giuseppe Caporaso, Annamaria Saltalamacchia, Francesca Califano, Bernardo Lanzillo, Marina Picillo, Paolo Barone, Lucio Santoro Neurology.2017; 89(8): 776. CrossRef
Arterial Stiffness and Cardiovascular Autonomic Dysfunction in Patients with Parkinson's Disease Joong-Seok Kim, Si-Hoon Lee, Yoon-Sang Oh, Jeong-Wook Park, Jae-Young An, Hyun-Seok Choi, Kwang-Soo Lee Neurodegenerative Diseases.2017; 17(2-3): 89. CrossRef
Prevalence and Prescribed Treatments of Orthostatic Hypotension in Institutionalized Patients with Parkinson’s Disease ALAJ Hommel, MJ Faber, NJ Weerkamp, JG van Dijk, BR Bloem, RT Koopmans Journal of Parkinson's Disease.2016; 6(4): 805. CrossRef
Objective: Although gastrointestinal dysfunctions occur in the majority of patients with Parkinson’s disease (PD), they are often unrecognized because many patients remain relatively asymptomatic in the early stage. We investigated the frequency of gastrointestinal symptoms in patients with PD using newly developed gastrointestinal symptom questionnaires. Methods: Early PD patients with a symptom duration not exceeding 3 years were included in this study. All PD patients were evaluated using a questionnaire, which consisted of three relevant domains: oropharyngoesophageal (10 items); gastric (3 items); and intestinal-anorectal (7 items). The frequency of symptoms was calculated as a proportion with an item score ≥ 2. Results: Of the 54 patients enrolled, 48 patients (88.9%) responded that bowel symptoms developed before the onset of Parkinsonian motor symptoms, and four patients reported that the onset of two types of symptoms (i.e., bowel and neurological) occurred approximately simultaneously, with only months between them. The frequencies of gastrointestinal symptoms are as follows: speech disturbance (40.7%), drooling (24.1%), sense of getting stuck (31.5%), choking (27.8%), globus pharyngis (16.7%), repetitive deglutition (29.6%), pain during swallowing (5.6%), food regurgitation (3.7%), acid reflux (7.4%), nausea/ vomiting (11.1%), early satiety (16.7%), postprandial fullness (14.8%), epigastric soreness (9.3%), abdominal pain (3.7%), constipation (46.3%), excessive strain during defecation (33.3%), fecal incontinence (7.4%), tenesmus (20.4%), loose stool or diarrhea (3.7%), and difficulty in relaxing anal sphincter (11.1%). Two patients were scored at zero. Conclusions: Our findings confirm that gastrointestinal dysfunction occurs in early PD in relatively high frequency.
Citations
Citations to this article as recorded by
Neuroimmune Connectomes in the Gut and Their Implications in Parkinson’s Disease Beatriz Thomasi, Luisa Valdetaro, Brian Gulbransen, Ana Lúcia Tavares-Gomes Molecular Neurobiology.2024; 61(4): 2081. CrossRef
Effect of Lycium ruthenicum and Lycium barbarum intake on Parkinson based on microbiology and metabonomics: A randomized pilot trial Lingyu Wu, Liwen Chu, Hongdou Cao, Qi Tian, Hua Gao, Jinghong Huo, Qinghan Gao Food Bioscience.2024; 57: 103548. CrossRef
The missing piece of the puzzle – The key role of the dietitian in the management of Parkinson's disease Richelle Flanagan, Carley Rusch, Fiona E. Lithander, Indu Subramanian Parkinsonism & Related Disorders.2024; 121: 106021. CrossRef
Gastric-filling ultrasonography to evaluate gastric motility in patients with Parkinson's disease Xianwei Zou, Xiaqing Chen, Yanxia Wen, Xiaofeng Jing, Man Luo, Fengyue Xin, Yao Tang, Mengfei Hu, Jian Liu, Fan Xu Frontiers in Neurology.2024;[Epub] CrossRef
Persistent intolerable abdominal pain in patients with Parkinson’s disease Hiroshi Kataoka, Kazuma Sugie Clinical Neurology and Neurosurgery.2023; 224: 107558. CrossRef
Striatal Dopaminergic Loss and Dysphagia in Parkinson Disease Ji Hwan Kim, Jonghu Jeon, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim Clinical Nuclear Medicine.2023; 48(2): 143. CrossRef
The gut microbiota is an emerging target for improving brain health during ageing Marcus Boehme, Katherine Elizabeth Guzzetta, Caroline Wasén, Laura Michelle Cox Gut Microbiome.2023;[Epub] CrossRef
6-OHDA-Induced Changes in Colonic Segment Contractility in the Rat Model of Parkinson’s Disease Maria Del Pilar Murillo, Ebba Johansson, Victoria Bryntesson, Patrik Aronsson, Gunnar Tobin, Michael Winder, Thomas Carlsson, Stephen Fink Gastroenterology Research and Practice.2023; 2023: 1. CrossRef
Efficacy of acupuncture for the treatment of Parkinson’s disease-related constipation (PDC): A randomized controlled trial Ying-Jia Li, Ian-I Leong, Jing-Qi Fan, Ming-Yue Yan, Xin Liu, Wei-Jing Lu, Yuan-Yuan Chen, Wei-Qiang Tan, Yu-Ting Wang, Li-Xing Zhuang Frontiers in Neuroscience.2023;[Epub] CrossRef
Considerations for developing a targeted amino acid supplement for people with Parkinson’s disease that promotes health while accounting for pathophysiology and medication interference Jacob E Earp, Cristina Colon-Semenza, Dara L LoBuono Nutrition Reviews.2023; 81(8): 1063. CrossRef
Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis Chuanqi Chu, Leilei Yu, Yiwen Li, Hang Guo, Qixiao Zhai, Wei Chen, Fengwei Tian Nutrients.2023; 15(7): 1737. CrossRef
The longitudinal progression of autonomic dysfunction in Parkinson's disease: A 7-year study Charlotte B. Stewart, David Ledingham, Victoria K. Foster, Kirstie N. Anderson, Sahana Sathyanarayana, Debra Galley, Nicola Pavese, Jacopo Pasquini Frontiers in Neurology.2023;[Epub] CrossRef
Association of dysphagia with altered brain glucose metabolism in Parkinson's disease Ji Yeon Oh, Eui Jin An, Young Lee, Seung Min Kim, Miju Cheon, Jun Yup Kim CNS Neuroscience & Therapeutics.2023; 29(9): 2498. CrossRef
Differential Findings on Anorectal Manometry in Patients with Parkinson's Disease and Defecatory Dysfunction Wendy Zhou, George Triadafilopoulos, Brooke Gurland, Houssam Halawi, Laren Becker, Patricia Garcia, Linda Nguyen, Mitchell Miglis, Srikanth Muppidi, Dong‐In Sinn, Safwan Jaradeh, Leila Neshatian Movement Disorders Clinical Practice.2023; 10(7): 1074. CrossRef
Abdominal pain in Parkinson’s disease A.A. Pilipovich, O.V. Vorobyova, S.A. Makarov Russian Journal of Pain.2023; 21(2): 12. CrossRef
Microbiome-Based Therapies in Parkinson’s Disease: Can Tuning the
Microbiota Become a Viable Therapeutic Strategy? Adejoke Y. Onaolapo, Folusho O. Ojo, Anthony T. Olofinnade, Joshua Falade, Ismail A. Lawal, Olakunle J. Onaolapo CNS & Neurological Disorders - Drug Targets.2023; 22(9): 1355. CrossRef
Constipation in Parkinson's Disease Eamonn M. M. Quigley Seminars in Neurology.2023; 43(04): 562. CrossRef
Autonomic symptoms in early-stage Parkinson’s patients and their relationship with cognition and disease parameters Esma KOBAK TUR, Eren GÖZKE Anatolian Current Medical Journal.2023; 5(4): 498. CrossRef
Lower gastrointestinal dysfunction in patients with Parkinson’s disease A.A. Pilipovich, O.V. Vorob’eva, S.A. Makarov, A.V. Kuchuk Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2023; 123(12): 42. CrossRef
Related Effects of Methamphetamine on the Intestinal Barrier via Cytokines, and Potential Mechanisms by Which Methamphetamine May Occur on the Brain-Gut Axis Yuansen Li, Deshenyue Kong, Ke Bi, Huayou Luo Frontiers in Medicine.2022;[Epub] CrossRef
Alpha-synuclein and tau are abundantly expressed in the ENS of the human appendix and monkey cecum Alexandra D. Zinnen, Jonathan Vichich, Jeanette M. Metzger, Julia C. Gambardella, Viktoriya Bondarenko, Heather A. Simmons, Marina E. Emborg, Stephan N. Witt PLOS ONE.2022; 17(6): e0269190. CrossRef
Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approaches Roongroj Bhidayasiri, Warongporn Phuenpathom, Ai Huey Tan, Valentina Leta, Saisamorn Phumphid, K. Ray Chaudhuri, Pramod Kumar Pal Frontiers in Aging Neuroscience.2022;[Epub] CrossRef
Mechanisms of development of constipation in Parkinson’s disease and therapeutic approaches E.A. Katunina, N.N. Shipilova, D.A. Katunin Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova.2022; 122(8): 21. CrossRef
Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease Huijia Yang, Song Li, Weidong Le Aging and disease.2022; 13(5): 1381. CrossRef
The interplay between the gut-brain axis and the microbiome: A perspective on psychiatric and neurodegenerative disorders Yasir Bashir, Asad U. Khan Frontiers in Neuroscience.2022;[Epub] CrossRef
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease Bai-Hua Sun, Tao Wang, Nian-Ying Li, Qiong Wu, Jin Qiao World Journal of Gastrointestinal Pharmacology and Therapeutics.2021; 12(1): 21. CrossRef
Characterization of Gastrointestinal Symptom Type and Severity in Parkinson's Disease: A Case–Control Study in an Australian Cohort Jade E. Kenna, Megan C. Bakeberg, Anastazja M. Gorecki, Alfred Chin Yen Tay, Samantha Winter, Frank L. Mastaglia, Ryan S. Anderton Movement Disorders Clinical Practice.2021; 8(2): 245. CrossRef
Granisetron, a selective 5-HT3 antagonist, reduces L-3,4-dihydroxyphenylalanine-induced abnormal involuntary movements in the 6-hydroxydopamine-lesioned rat Cynthia Kwan, Imane Frouni, Dominique Bédard, Adjia Hamadjida, Philippe Huot Behavioural Pharmacology.2021; 32(1): 43. CrossRef
Deglutition Impairment during Dual Task in Parkinson Disease Is Associated with Cognitive Status Luciana Grolli Ardenghi, Alana Verza Signorini, Gerson Schulz Maahs, Fabio Selaimen, Konrado Massing Deutsch, Silvia Dornelles, Carlos Roberto de Mello Rieder International Archives of Otorhinolaryngology.2021; 25(01): e41. CrossRef
Spectrum of Non-Motor Symptoms in Parkinson's Disease Maithrayie Kumaresan, Safeera Khan Cureus.2021;[Epub] CrossRef
Onset of Skin, Gut, and Genitourinary Prodromal Parkinson's Disease: A Study of 1.5 Million Veterans Gregory D. Scott, Miranda M. Lim, Matthew G. Drake, Randy Woltjer, Joseph F. Quinn Movement Disorders.2021; 36(9): 2094. CrossRef
The Gastrointestinal Dysfunction Scale for Parkinson's Disease Marta Camacho, Julia C. Greenland, Caroline H. Williams‐Gray Movement Disorders.2021; 36(10): 2358. CrossRef
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, Anna Serefko, Marcin Włodarczyk, Anna Zielińska, Ewa Poleszak, Jakub Fichna, Piotr Wlaź Pharmacological Research.2021; 172: 105840. CrossRef
Neuro-Immunity and Gut Dysbiosis Drive Parkinson’s Disease-Induced Pain Katiane Roversi, Natalia Callai-Silva, Karine Roversi, May Griffith, Christos Boutopoulos, Rui Daniel Prediger, Sébastien Talbot Frontiers in Immunology.2021;[Epub] CrossRef
Autonomic dysfunction in Parkinson’s disease: Implications for pathophysiology, diagnosis, and treatment Zhichun Chen, Guanglu Li, Jun Liu Neurobiology of Disease.2020; 134: 104700. CrossRef
Double‐Blind, Randomized, Placebo‐Controlled Trial of DA‐9701 in Parkinson's Disease: PASS‐GI Study Ji‐Hyun Choi, Jee‐Young Lee, Jin Whan Cho, Seong‐Beom Koh, Young Soon Yang, Dalla Yoo, Cheol‐Min Shin, Hee Tae Kim Movement Disorders.2020; 35(11): 1966. CrossRef
Parkinson disease and the gut: new insights into pathogenesis and clinical relevance R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri Nature Reviews Gastroenterology & Hepatology.2020; 17(11): 673. CrossRef
Excessive buccal saliva in patients with Parkinson’s disease of the French COPARK cohort Olivier Rascol, Laurence Negre-Pages, Philippe Damier, Arnaud Delval, Pascal Derkinderen, Alain Destée, Margherita Fabbri, Wassilios G. Meissner, Amine Rachdi, François Tison, Santiago Perez-Lloret Journal of Neural Transmission.2020; 127(12): 1607. CrossRef
Struktur und Efferenzen der Substantia nigra pars compacta beim idiopathischen Parkinson-Syndrom Peter Urban, Bjorn Falkenburger, Wolfgang H. Jost, Gerhard Ransmayr, Peter Riederer, Christian Winkler Fortschritte der Neurologie · Psychiatrie.2020; 88(09): 591. CrossRef
Parkinson’s disease: Are gut microbes involved? Yogesh Bhattarai, Purna C. Kashyap American Journal of Physiology-Gastrointestinal and Liver Physiology.2020; 319(5): G529. CrossRef
Does Bilateral Deep Brain Stimulation of the Subthalamic Nucleus Modify Ano-Rectal Motility in Parkinson’s Disease? Results of a Randomized Cross-Over Study Guillaume Gourcerol, David Maltete, Nathalie Chastan, Marie Laure Welter, Anne Marie Leroi, Stéphane Derrey Neuromodulation: Technology at the Neural Interface.2019; 22(4): 478. CrossRef
Probiotics for Parkinson’s Disease Gazerani International Journal of Molecular Sciences.2019; 20(17): 4121. CrossRef
Colon dysregulation in methamphetamine self-administering HIV-1 transgenic rats Amanda L. Persons, Brinda D. Bradaric, Hemraj B. Dodiya, Michael Ohene-Nyako, Christopher B. Forsyth, Ali Keshavarzian, Maliha Shaikh, T. Celeste Napier, Shilpa J. Buch PLOS ONE.2018; 13(1): e0190078. CrossRef
Induction of alpha-synuclein pathology in the enteric nervous system of the rat and non-human primate results in gastrointestinal dysmotility and transient CNS pathology Fredric P. Manfredsson, Kelvin C. Luk, Matthew J. Benskey, Aysegul Gezer, Joanna Garcia, Nathan C. Kuhn, Ivette M. Sandoval, Joseph R. Patterson, Alana O'Mara, Reid Yonkers, Jeffrey H. Kordower Neurobiology of Disease.2018; 112: 106. CrossRef
Dysbiosis of gut microbiota and microbial metabolites in Parkinson’s Disease Meng-Fei Sun, Yan-Qin Shen Ageing Research Reviews.2018; 45: 53. CrossRef
Parkinson’s Disease and Current Treatments for Its Gastrointestinal Neurogastromotility Effects Chethan Ramprasad, Jane Yellowlees Douglas, Baharak Moshiree Current Treatment Options in Gastroenterology.2018; 16(4): 489. CrossRef
Transdermal rotigotine patch in Parkinson’s disease with a history of intestinal operation Takashi Ogawa, Genko Oyama, Nobutaka Hattori BMJ Case Reports.2018; : bcr-2017-223722. CrossRef
α-Synuclein in the colon and premotor markers of Parkinson disease in neurologically normal subjects Joong-Seok Kim, In-Seok Park, Hyung-Eun Park, Su-Young Kim, Jung A Yun, Chan Kwon Jung, Hye-Young Sung, Jin-Kwon Lee, Won-Kyung Kang Neurological Sciences.2017; 38(1): 171. CrossRef
The Threshold Theory for Parkinson's Disease Simone Engelender, Ole Isacson Trends in Neurosciences.2017; 40(1): 4. CrossRef
Constipation in parkinson's disease: Subjective symptoms, objective markers, and new perspectives Karoline Knudsen, Klaus Krogh, Karen Østergaard, Per Borghammer Movement Disorders.2017; 32(1): 94. CrossRef
Is Levodopa Pharmacokinetics in Patients with Parkinson’s Disease Depending on Gastric Emptying? Maria Nord, Anita Kullman, Ulf Hannestad, Nil Dizdar Advances in Parkinson's Disease.2017; 06(01): 1. CrossRef
Validation of the Korean Version of the Scale for Outcomes in Parkinson’s Disease-Autonomic Ji-Young Kim, In-Uk Song, Seong-Beom Koh, Tae-Beom Ahn, Sang Jin Kim, Sang-Myung Cheon, Jin Whan Cho, Yun Joong Kim, Hyeo-Il Ma, Mee-Young Park, Jong Sam Baik, Phil Hyu Lee, Sun Ju Chung, Jong-Min Kim, Han-Joon Kim, Young-Hee Sung, Do Young Kwon, Jae-Hyeo Journal of Movement Disorders.2017; 10(1): 29. CrossRef
Gastroesophageal reflux disease with proton pump inhibitor use is associated with an increased risk of osteoporosis: a nationwide population-based analysis C.-H. Chen, C.-L. Lin, C.-H. Kao Osteoporosis International.2016; 27(6): 2117. CrossRef
Parkinson Disease-Mediated Gastrointestinal Disorders and Rational for Combinatorial Therapies Syed Ali, Ning Yin, Arkam Rehman, Verline Justilien Medical Sciences.2016; 4(1): 1. CrossRef
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models C. Pellegrini, R. Colucci, L. Antonioli, E. Barocelli, V. Ballabeni, N. Bernardini, C. Blandizzi, W. J. de Jonge, M. Fornai Neurogastroenterology & Motility.2016; 28(12): 1781. CrossRef
Gut dysfunction in Parkinson's disease Adreesh Mukherjee, Atanu Biswas, Shyamal Kumar Das World Journal of Gastroenterology.2016; 22(25): 5742. CrossRef
Inflammation is genetically implicated in Parkinson’s disease N. Dzamko, C.L Geczy, G.M Halliday Neuroscience.2015; 302: 89. CrossRef
Alteration of enteric monoamines with monoamine receptors and colonic dysmotility in 6-OHDA-induced Parkinson’s disease rats Xiaoli Zhang, Yun Li, Chenzhe Liu, Ruifang Fan, Ping Wang, Lifei Zheng, Feng Hong, Xiaoyan Feng, Yue Zhang, Lisheng Li, Jinxia Zhu Translational Research.2015;[Epub] CrossRef
The treatment of gastroparesis, constipation and small intestinal bacterial overgrowth syndrome in patients with Parkinson’s disease Jose L Barboza, Michael S Okun, Baharak Moshiree Expert Opinion on Pharmacotherapy.2015; 16(16): 2449. CrossRef
Gastrointestinal Dysfunctions in Parkinson’s Disease Joong-Seok Kim, Hey Young Sung Journal of the Korean Neurological Association.2015; 33(4): 247. CrossRef